Medtronic Logo

Medtronic Announces First Patient Treated in Global Collaboration with Cydar Medical

By MedTech Intelligence Staff
No Comments
Medtronic Logo

“This cutting-edge technology empowers us with the ability to navigate complex vascular procedures with greater precision, ensuring optimal outcomes for our patients. We are honored to be a part of this innovative program.”

Medtronic announced that the first patient in a 40-site global pilot program that brings Cydar Medical’s artificial intelligence (AI) solution, Cydar Maps, into the clinical environment has been treated. Cydar Maps generates a 3D map of patient soft tissue to support and integrate pre-operative planning, intra-operative guidance and post-operative review of endovascular minimally invasive surgery, using AI to update the map throughout the patient journey.

Medtronic chose Cydar Medical to pilot with because Cydar Maps has been shown in independent studies to offer a number of benefits, including halving the radiation exposure for patients and the clinical team, simplifying the clinical workflow and increasing clinician confidence, which in turn can significantly reduce procedure times. The first patient in the pilot program received endovascular treatment earlier this month in conjunction with Cydar’s Maps at Edward Hospital in Naperville, Illinois.

“This is a significant milestone in Medtronic’s collaboration with Cydar Medical as we aim to revolutionize endovascular aortic treatment with cutting-edge, digital solutions,” said Nina Goodheart, SVP and President of the Structural Heart & Aortic business at Medtronic. “We look forward to continued progress toward our vision to provide physicians with enhanced knowledge to get the best possible outcomes for their patients.”

Medtronic and Cydar anticipate this pilot program will be the first step in the development of predictive analytics to support procedure planning, by assessing factors such as the risk of endoleaks, sac regression probability and more.

“This cutting-edge technology empowers us with the ability to navigate complex vascular procedures with greater precision, ensuring optimal outcomes for our patients. We are honored to be a part of this innovative program and are eager to contribute to the advancement of endovascular aortic surgery,“ said George Pontikis, MD, vascular surgeon at Edward Hospital in Naperville, Illinois, who treated the first patient.

 

Related Articles

  • Lorenzo Gutierrez, Starfish Medical

    Imagine a patient undergoing therapy being relaxed and enjoying the treatment, or receiving rewards for taking medicine religiously and on time. Creating a game-like experience can change patient perception of medical devices from boring or scary to engaging and attractive.…

  • Leslie Trigg Outset Medical

    Leslie Trigg, CEO of Outset Medical, is the new Chair of The Medical Device Manufacturers Association (MDMA) Board of Directors.

  • Korey Johnson

    There are several tactical approaches to design that can help medtech manufacturers inspire patient confidence in their products and ensure proper usage. Following are three ways you can help ease the burden of delivering and receiving quality care through product…

  • FFRangio System

    Medtronic will invest up to $75 million and immediately begin co-promotion of CathWorks’ FFRangio System for the noninvasive diagnosis of CAD in the U.S., Europe and Japan, where it is commercially available.

About The Author

MedTech Intelligence

Leave a Reply

Your email address will not be published. Required fields are marked *